Hospitalized patients at high risk who are vaccinated have lower rates of MI, TIA, cardiac arrest, death
FRIDAY, Aug. 7, 2020 (HealthDay News) — Flu vaccination is underused in high-risk patients but is associated with reduced rates of cardiovascular events among patients who do receive it, according to a study presented at the American Heart Association Basic Cardiovascular Sciences 2020 Scientific Sessions, held virtually from July 27 to 30.
Roshni A. Mandania, from the Texas Tech University Health Sciences Center Paul L. Foster School of Medicine in El Paso, and colleagues investigated the impact of flu vaccination on various cardiovascular outcomes among groups at high risk for influenza and its complications (e.g., adults ≥50 years, people with chronic medical conditions or AIDS, people at nursing facilities, American Indians and Alaskan Natives, and obese people). The analysis included data for 7,056,314 high-risk patients participating in the 2014 National Inpatient Sample Database.
The researchers identified 168,325 flu vaccinations among the high-risk patients during hospitalization. Older adults were less likely to be vaccinated during hospitalization compared with the general population (1.8 versus 15.3 percent). Among those at high risk who had the flu vaccination, there was a lower risk for myocardial infarction, mortality, transient ischemic attacks, and cardiac arrest.
“The results we found are staggering. It’s hard to ignore the positive effect the flu vaccine can have on serious cardiac complications,” Mandania said in a statement. “Some people don’t view flu vaccinations as necessary or important, and many may face barriers accessing health care including receiving the flu vaccine.”
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer
Mental Distress, Fatigue Common in Childhood Survivors of Leukemia, Lymphoma
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine
Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum